SignPath Pharma Inc. logo

SignPath Pharma Inc. jobs and careers

United States

About SignPath Pharma Inc.

SignPath Pharma (www.signpathpharma.com) is a clinical stage biotechnology company (Delaware C Corp.) founded in 2006. Currently, SignPath is actively developing products to treat cancer and mitigate drug-induced cardiac arrhythmia, which is a serious and common side effect of many drugs, and heart muscle damage caused by chemotherapy.

Founded in 2006 by Arthur P. Bollon and Bruce Meyers.

Founded
2006
Employees
11 to 50
Total funding
$7.3M
Headquarters
United States

Leadership

The top of SignPath Pharma Inc.'s org chart, with how many people report into each leader.

KLPhoto of Kai Larson

Kai Larson

President